Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

Neurofibromatose

Die Neurofibromatose ist eine Erbkrankheit, Neurofibrome(gutartige Nierentumore) gekennzeichnet ist.

Symptome

Cafe-au-lait-Flecke
Die Neurofibromatose ist wohl die wichtigste Erkrankung mit Cafe-au-lait-Flecken.

Gliederung

Erbliche Tumorerkrankungen
Hereditäre Nierentumoren
Hereditäre maligne Bluterkrankungen
Infantiles kapilläres Hämangiom
Neurofibromatose
Legius-Syndrom
SPRED1
Neurofibromatose 1
NF1
Neurofibromatose-Noonan-Syndrom
NF1
Spinale Form der Neurofibromatose
NF1
Watson-Syndrome
NF1

Referenzen:

1.

Wang Q et. al. (2003) Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.

[^]
2.

Bahuau M et. al. (2001) GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype.

[^]
3.

Allanson JE et. al. (1985) Noonan phenotype associated with neurofibromatosis.

[^]
4.

Heim RA et. al. (1994) Screening for truncated NF1 proteins.

[^]
5.

Colley A et. al. (1996) Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.

[^]
6.

Upadhyaya M et. al. (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.

[^]
7.

Silva AJ et. al. (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I.

[^]
8.

Side L et. al. (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.

[^]
9.

Gutmann DH et. al. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

[^]
10.

Skuse GR et. al. (1997) RNA processing and clinical variability in neurofibromatosis type I (NF1).

[^]
11.

Klose A et. al. (1998) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.

[^]
12.

Kluwe L et. al. (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.

[^]
13.

Eisenbarth I et. al. (2000) Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.

[^]
14.

Gutzmer R et. al. (2000) Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.

[^]
15.

Gervasini C et. al. (2002) Tandem duplication of the NF1 gene detected by high-resolution FISH in the 17q11.2 region.

[^]
16.

Upadhyaya M et. al. (2003) Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1.

[^]
17.

Baralle D et. al. (2003) Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).

[^]
18.

Kluwe L et. al. (2003) NF1 mutations and clinical spectrum in patients with spinal neurofibromas.

[^]
19.

Wiest V et. al. (2003) Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.

[^]
20.

Ferner RE et. al. (2004) Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).

[^]
21.

Ragge NK et. al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations.

[^]
22.

Bertola DR et. al. (2005) Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.

[^]
23.

De Luca A et. al. (2005) NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.

[^]
24.

Stevenson DA et. al. (2006) Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.

[^]
25.

Kolanczyk M et. al. (2007) Multiple roles for neurofibromin in skeletal development and growth.

[^]
26.

Henderson RA et. al. (2007) Inherited PAX6, NF1 and OTX2 mutations in a child with microphthalmia and aniridia.

[^]
27.

Thiel C et. al. (2009) Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.

[^]
28.

Nyström AM et. al. (2009) Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.

[^]
29.

Quattrin T et. al. (1987) Vertical transmission of the neurofibromatosis/Noonan syndrome.

[^]
30.

None (1987) Evidence that the "neurofibromatosis-Noonan syndrome" is a variant of von Recklinghausen neurofibromatosis.

[^]
31.

Abuelo DN et. al. (1988) Neurofibromatosis with fully expressed Noonan syndrome.

[^]
32.

Opitz JM et. al. (1985) The neurofibromatosis-Noonan syndrome.

[^]
33.

Jamieson CR et. al. (1994) Mapping a gene for Noonan syndrome to the long arm of chromosome 12.

[^]
34.

Bahuau M et. al. (1996) Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association.

[^]
35.

Bahuau M et. al. (1998) Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome.

[^]
36.

Klopfenstein KJ et. al. () Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia: a report of two cases.

[^]
37.

Pearson-Webb MA et. al. (1986) Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules.

[^]
38.

Krone W et. al. (1986) Cell culture studies on neurofibromatosis (von Recklinghausen). V. Monosomy 22 and other chromosomal anomalies in cultures from peripheral neurofibromas.

[^]
39.

Duncan AM et. al. (1987) Neurofibromatosis in a man with a ring 22: in situ hybridization studies.

[^]
40.

Seizinger BR et. al. (1987) Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.

[^]
41.

Martuza RL et. al. (1988) Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).

[^]
42.

Wertelecki W et. al. (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred.

[^]
43.

Mrázek J et. al. (1988) Diagnosis, size, and operation results in 41 acoustic neurinomas.

[^]
44.

Lee DK et. al. (1969) Familial central nervous system neoplasia. Case report of a family with von Recklinghausen's neurofibromatosis.

[^]
45.

Young DF et. al. (1970) Bilateral acoustic neuroma in a large kindred.

[^]
46.

None (1969) Acoustic neurinomas. Pathology and differential diagnosis.

[^]
47.

None (1968) Case reports and technical note. Familial bilateral acoustic neuroma affecting 14 members from four generations. Case report.

[^]
48.

Kanter WR et. al. (1980) Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis.

[^]
49.

None (1981) Central neurofibromatosis with bilateral acoustic neuroma.

[^]
50.

Martuza RL et. al. (1982) Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment.

[^]
51.

None (1995) Asbestos and mesothelioma: genetic lessons from a tragedy.

[^]
52.

Ragge NK et. al. (1995) Ocular abnormalities in neurofibromatosis 2.

[^]
53.

Parry DM et. al. (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.

[^]
54.

Watson CJ et. al. (1993) A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.

[^]
55.

None (1994) National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. The Consensus Development Panel.

[^]
56.

Bouzas EA et. al. (1993) Lens opacities in neurofibromatosis 2: further significant correlations.

[^]
57.

Rouleau GA et. al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

[^]
58.

Ruttledge MH et. al. (1993) Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.

[^]
59.

Bouzas EA et. al. (1993) Visual impairment in patients with neurofibromatosis 2.

[^]
60.

Parry DM et. al. (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

[^]
61.

Ruttledge MH et. al. (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.

[^]
62.

Kehrer-Sawatzki H et. al. (1997) Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.

[^]
63.

Evans DG et. al. (1998) Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

[^]
64.

Kondziolka D et. al. (1998) Long-term outcomes after radiosurgery for acoustic neuromas.

[^]
65.

Pitts LH et. al. (1998) Treatment of acoustic neuromas.

[^]
66.

Wu CL et. al. (1998) Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.

[^]
67.

Evans DG et. al. (1999) Paediatric presentation of type 2 neurofibromatosis.

[^]
68.

Kluwe L et. al. (2000) Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.

[^]
69.

Egan RA et. al. (2001) Monocular elevator paresis in neurofibromatosis type 2.

[^]
70.

Gijtenbeek JM et. al. (2001) Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2.

[^]
71.

Baser ME et. al. (2001) Maternal gene effect in neurofibromatosis 2: fact or artefact?

[^]
72.

Mohyuddin A et. al. (2002) Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.

[^]
73.

Baser ME et. al. (2002) Neurofibromatosis 2 and malignant mesothelioma.

[^]
74.

Baser ME et. al. (2002) Predictors of the risk of mortality in neurofibromatosis 2.

[^]
75.

Baser ME et. al. (2002) Evaluation of clinical diagnostic criteria for neurofibromatosis 2.

[^]
76.

Bovie C et. al. (2003) Neurofibromatosis 2 in a patient with a de novo balanced reciprocal translocation 46,X,t(X;22)(p11.2;q11.2).

[^]
77.

None (1964) ASSOCIATION OF BILATERAL 8TH NERVE TUMORS WITH MENINGIOMAS IN VON RECKLINGHAUSEN'S DISEASE.

[^]
78.

Baser ME et. al. (2003) Genotype-phenotype correlations for cataracts in neurofibromatosis 2.

[^]
79.

Baser ME et. al. (2004) Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.

[^]
80.

Tsilchorozidou T et. al. (2004) Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.

[^]
81.

Baser ME et. al. (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

[^]
82.

Evans DG et. al. (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.

[^]
83.

McLaughlin ME et. al. (2007) Ocular pathologic findings of neurofibromatosis type 2.

[^]
84.

Asthagiri AR et. al. (2009) Neurofibromatosis type 2.

[^]
85.

Evans DG et. al. (2009) An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).

[^]
86.

Feiling A et. al. (1920) A FAMILIAL FORM OF ACOUSTIC TUMOUR.

[^]
87.

Baser ME et. al. (2011) Empirical development of improved diagnostic criteria for neurofibromatosis 2.

[^]
88.

Stambolian D et. al. (1988) Gene location in neurofibromatosis.

[^]
89.

Craddock GR et. al. (1988) Neurofibromatosis and renal artery stenosis: a case of familial incidence.

[^]
90.

Fitzpatrick AP et. al. (1988) Familial neurofibromatosis and hypertrophic cardiomyopathy.

[^]
91.

Samuelsson B et. al. (1988) Relative fertility and mutation rate in neurofibromatosis.

[^]
92.

Dunn BG et. al. (1985) A genetic linkage study in 15 families of individuals with von Recklinghausen neurofibromatosis.

[^]
93.

None (1965) Deficiency of erythrocyte galactokinase in a patient with galactose diabetes.

[^]
94.

Schenkein I et. al. (1974) Increased nerve-growth-stimulating activity in disseminated neurofibromatosis.

[^]
95.

Salyer WR et. al. (1974) The vascular lesions of neurofibromatosis.

[^]
96.

Brunner H et. al. (1974) Chronic mesenteric arterial insufficiency caused by vascular neurofibromatosis. A case report.

[^]
97.

Rosenquist GC et. al. (1970) Acquired right ventricular outflow obstruction in a child with neurofibromatosis.

[^]
98.

Hochberg FH et. al. (1974) Gastrointestinal involvement in von Recklinghausen's neurofibromatosis.

[^]
99.

Knight WA et. al. (1973) Neurofibromatosis associated with malignant neurofibromas.

[^]
100.

Massaro D et. al. (1966) Fibrosing alveolitis: its occurrence, roentgenographic, and pathologic features in von Recklinghausen's neurofibromatosis.

[^]
101.

Grant WM et. al. (1968) Distinctive gonioscopic findings in glaucoma due to neurofibromatosis.

[^]
102.

Diekmann L et. al. (1967) [Unusual manifestations of neurofibromatosis (von Recklinghausen's disease) in childhood. Abdominal tumor with clitoris hypertrophy. Renal hypertension caused by renal artery stenosis. Monozygotic twins--plexiform neuroma in the head region and glaucoma].

[^]
103.

Benedict PH et. al. (1968) Melanotic macules in Albright's syndrome and in neurofibromatosis.

[^]
104.

Miles J et. al. (1969) Intrathoracic meningocele. Its development and association with neurofibromatosis.

[^]
105.

Fienman NL et. al. (1970) Neurofibromatosis in childhood.

[^]
106.

Buntin PT et. al. (1970) Gastrointestinal neurofibromatosis. A rare cause of chronic anemia.

[^]
107.

Wallis K et. al. (1970) Hypertension in a case of von Recklinghausen's neurofibromatosis.

[^]
108.

Boudin G et. al. (1970) [Multiple tumours of the nervous system in Recklinghausen's disease. An anatomo-clinical case with chromophobe adenoma of the pituitary gland].

[^]
109.

Charron JW et. al. (1970) Neurofibromatosis of bladder: case report and review of literature.

[^]
110.

Johnson BL et. al. (1970) Café au lait spot in neurofibromatosis and in normal individuals.

[^]
111.

Allan TN et. al. (1970) Neurofibromatosis of the renal artery.

[^]
112.

Fialkow PJ et. al. (1971) Multiple cell origin of hereditary neurofibromas.

[^]
113.

Newman A et. al. (1971) Bilateral neurofibroma of the intrathoracic vagus associated with von Recklinghausen's disease.

[^]
114.

Izumi AK et. al. (1971) Von Recklinghausen's disease associated with multiple neurolemomas.

[^]
115.

Smith CJ et. al. (1970) Renal artery dysplasia as a cause of hypertension in neurofibromatosis.

[^]
116.

Bidot-Lopez P et. al. () Enhanced viral transformation of skin fibroblasts from neurofibromatosis patients.

[^]
117.

Horwich A et. al. (1983) Brief clinical report: aqueductal stenosis leading to hydrocephalus--an unusual manifestation of neurofibromatosis.

[^]
118.

Voutsinas S et. al. (1983) The infrequency of malignant disease in diaphyseal aclasis and neurofibromatosis.

[^]
119.

None () Von Recklinghausen's vasculopathy.

[^]
120.

Riccardi VM et. al. (1984) The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

[^]
121.

Satran L et. al. (1980) Neurofibromatosis with congenital glaucoma and buphthalmos in a newborn.

[^]
122.

Pellock JM et. al. (1980) Childhood hypertensive stroke with neurofibromatosis.

[^]
123.

Erickson RP et. al. (1980) Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis.

[^]
124.

Stanley JC et. al. (1981) Pediatric renal artery occlusive disease and renovascular hypertension. Etiology, diagnosis, and operative treatment.

[^]
125.

Fabricant RN et. al. (1981) Increased serum levels of nerve growth factor in von Recklinghausen's disease.

[^]
126.

None (1981) Von Recklinghausen neurofibromatosis.

[^]
127.

Kaplan J et. al. (1982) Familial T-cell lymphoblastic lymphoma: association with Von Recklinghausen neurofibromatosis and Gardner syndrome.

[^]
128.

Clark RD et. al. (1982) Familial neurofibromatosis and juvenile chronic myelogenous leukemia.

[^]
129.

Rockower S et. al. (1982) Dislocation of the spine in neurofibromatosis. A report of two cases.

[^]
130.

Kalff V et. al. (1982) The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.

[^]
131.

Perry HD et. al. (1982) Iris nodules in von Recklinghausen's Neurofibromatosis. Electron microscopic confirmation of their melanocytic origin.

[^]
132.

Friedman JM et. al. (1982) Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.

[^]
133.

None (1982) Neurofibromatosis: clinical heterogeneity.

[^]
134.

Listernick R et. al. (1995) Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.

[^]
135.

Molloy PT et. al. (1995) Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity.

[^]
136.

Wolkenstein P et. al. (1995) More on the frequency of segmental neurofibromatosis.

[^]
137.

Legius E et. al. (1995) Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.

[^]
138.

Parazzini C et. al. (1995) Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation.

[^]
139.

Colman SD et. al. (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.

[^]
140.

Eichhorn C et. al. (1995) Dural ectasia in von Recklinghausen's disease of the lumbar spine: a case report.

[^]
141.

Ingordo V et. al. (1995) Segmental neurofibromatosis: is it uncommon or underdiagnosed?

[^]
142.

Heim RA et. al. (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

[^]
143.

Sutphen R et. al. (1995) Clitoromegaly in neurofibromatosis.

[^]
144.

Garty BZ et. al. (1994) Neurofibromatosis type 1 in Israel: survey of young adults.

[^]
145.

None (1994) Intracranial fusiform aneurysms in von Recklinghausen's disease: case report and literature review.

[^]
146.

Lázaro C et. al. (1994) Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.

[^]
147.

Listernick R et. al. (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

[^]
148.

Kayes LM et. al. (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.

[^]
149.

Hofman KJ et. al. (1994) Neurofibromatosis type 1: the cognitive phenotype.

[^]
150.

Lehrnbecher T et. al. (1994) Neurofibromatosis presenting as a severe systemic vasculopathy.

[^]
151.

Kurotaki H et. al. (1993) Multiple papillary adenomas of type II pneumocytes found in a 13-year-old boy with von Recklinghausen's disease.

[^]
152.

Shannon KM et. al. (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

[^]
153.

Ragge NK et. al. (1993) Images of Lisch nodules across the spectrum.

[^]
154.

Easton DF et. al. (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

[^]
155.

Friedman JM et. al. (1993) National Neurofibromatosis Foundation International Database.

[^]
156.

Legius E et. al. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.

[^]
157.

Stark M et. al. (1995) Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene.

[^]
158.

Upadhyaya M et. al. (1995) Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

[^]
159.

Leppig KA et. al. (1996) The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization.

[^]
160.

Colman SD et. al. (1996) Somatic mosaicism in a patient with neurofibromatosis type 1.

[^]
161.

Sakaguchi N et. al. (1996) A case of von Recklinghausen's disease with bilateral pheochromocytoma-malignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors.

[^]
162.

Barrall JL et. al. () Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis.

[^]
163.

Sawada S et. al. (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma.

[^]
164.

Hünerbein M et. al. (1996) Biliary obstruction caused by a multifocal duodenal neurosarcoma in a patient with von Recklinghausen's disease.

[^]
165.

Nopajaroonsri C et. al. (1996) Venous aneurysm, arterial dysplasia, and near-fatal hemorrhages in neurofibromatosis type 1.

[^]
166.

Shen MH et. al. (1996) Molecular genetics of neurofibromatosis type 1 (NF1).

[^]
167.

Abeliovich D et. al. (1995) Familial café au lait spots: a variant of neurofibromatosis type 1.

[^]
168.

Dugoff L et. al. (1996) Neurofibromatosis type 1 and pregnancy.

[^]
169.

None (1997) Precocious puberty in two children with neurofibromatosis type I in the absence of optic chiasmal glioma.

[^]
170.

Friedman JM et. al. (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

[^]
171.

Serra E et. al. (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.

[^]
172.

Cnossen MH et. al. (1998) Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

[^]
173.

Park VM et. al. (1998) Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

[^]
174.

Cook DL et. al. (1998) Modeling stochastic gene expression: implications for haploinsufficiency.

[^]
175.

McGaughran JM et. al. (1999) A clinical study of type 1 neurofibromatosis in north west England.

[^]
176.

Stevenson DA et. al. (1999) Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1.

[^]
177.

Chu MH et. al. (1999) Gastro-intestinal bleeding caused by leiomyoma of the small intestine in a child with neurofibromatosis.

[^]
178.

Gutmann DH et. al. (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.

[^]
179.

Mukonoweshuro W et. al. (1999) Neurofibromatosis type 1: the role of neuroradiology.

[^]
180.

Clementi M et. al. (1999) Neurofibromatosis type 1 growth charts.

[^]
181.

Cichowski K et. al. (1999) Mouse models of tumor development in neurofibromatosis type 1.

[^]
182.

Vogel KS et. al. (1999) Mouse tumor model for neurofibromatosis type 1.

[^]
183.

Ingram DA et. al. (2000) Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.

[^]
184.

John AM et. al. (2000) A search for evidence of somatic mutations in the NF1 gene.

[^]
185.

Koivunen J et. al. (2000) New function for NF1 tumor suppressor.

[^]
186.

DeBella K et. al. (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

[^]
187.

Yamauchi T et. al. (2000) Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.

[^]
188.

Rutkowski JL et. al. (2000) Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.

[^]
189.

Waggoner DJ et. al. (2000) Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.

[^]
190.

None (2000) Parents' responses to their child's diagnosis of neurofibromatosis 1.

[^]
191.

Tinschert S et. al. (2000) Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene.

[^]
192.

King AA et. al. (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

[^]
193.

Reilly KM et. al. (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.

[^]
194.

Poyhonen M et. al. (2000) Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland.

[^]
195.

Yasunari T et. al. (2000) Frequency of choroidal abnormalities in neurofibromatosis type 1.

[^]
196.

Lin AE et. al. (2000) Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

[^]
197.

Szudek J et. al. (2000) Growth in North American white children with neurofibromatosis 1 (NF1).

[^]
198.

Serra E et. al. (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.

[^]
199.

Hamilton SJ et. al. (2000) Insights into the pathogenesis of neurofibromatosis 1 vasculopathy.

[^]
200.

None (2000) The vasculopathy of NF1 and histogenesis control genes.

[^]
201.

Otsuka F et. al. (2001) Lisch nodules and skin manifestation in neurofibromatosis type 1.

[^]
202.

Costa RM et. al. (2001) Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1.

[^]
203.

Rasmussen SA et. al. (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

[^]
204.

Balcer LJ et. al. (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

[^]
205.

Parsa CF et. al. (2001) Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging.

[^]
206.

Hamilton SJ et. al. (2001) Cardiac findings in an individual with neurofibromatosis 1 and sudden death.

[^]
207.

Serra E et. al. (2001) Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.

[^]
208.

Leroy K et. al. (2001) Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.

[^]
209.

Gutmann DH et. al. (2001) Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.

[^]
210.

Costa RM et. al. (2002) Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.

[^]
211.

Sperfeld AD et. al. (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.

[^]
212.

Zhu Y et. al. (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

[^]
213.

Evans DG et. al. (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

[^]
214.

Singhal S et. al. (2002) Neurofibromatosis type 1 and sporadic optic gliomas.

[^]
215.

Friedman JM et. al. () Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

[^]
216.

Kemkemer R et. al. (2002) Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro.

[^]
217.

Rosser T et. al. (2002) Neurofibromas in children with neurofibromatosis 1.

[^]
218.

Gitler AD et. al. (2003) Nf1 has an essential role in endothelial cells.

[^]
219.

Khosrotehrani K et. al. (2003) Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients.

[^]
220.

Szudek J et. al. (2003) Patterns of associations of clinical features in neurofibromatosis 1 (NF1).

[^]
221.

Ruggieri M et. al. (2003) From Aldrovandi's "Homuncio" (1592) to Buffon's girl (1749) and the "Wart Man" of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?

[^]
222.

Schrimsher GW et. al. (2003) Visual-spatial performance deficits in children with neurofibromatosis type-1.

[^]
223.

None (1952) Rickets and osteomalacia from renal tubule defects.

[^]
224.

None (1953) Familial fibromatosis of small intestine.

[^]
225.

HAYES DM et. al. (1961) Von Recklinghausen's disease with massive intra-abdominal tumor and spontaneous hypoglycemia: metabolic studies before and after perfusion of abdominal cavity with nitrogen mustard.

[^]
226.

MANLEY KA et. al. (1961) Some heritable causes of gastrointestinal disease. Special reference to hemorrhage.

[^]
227.

None (1962) Encapsulated glioma of the Sylvian fissure associated with neurofibromatosis. Report of a case with histopathological comparison of surgical lesion and autopsy specimen following recurrence.

[^]
228.

D'AGOSTINO AN et. al. (1963) SARCOMAS OF THE PERIPHERAL NERVES AND SOMATIC SOFT TISSUES ASSOCIATED WITH MULTIPLE NEUROFIBROMATOSIS (VON RECKLINGHAUSEN'S DISEASE).

[^]
229.

None (1964) AXILLARY FRECKLING AS A DIAGNOSTIC AID IN NEUROFIBROMATOSIS.

[^]
230.

None (1961) [Hereditary neurofibromatosis with a wide phenotypic spectrum (the family Sn.)].

[^]
231.

Vandenbroucke I et. al. (2004) Genetic and clinical mosaicism in a patient with neurofibromatosis type 1.

[^]
232.

None (2003) It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

[^]
233.

Yang FC et. al. (2003) Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.

[^]
234.

Liu GT et. al. (2004) Optic radiation involvement in optic pathway gliomas in neurofibromatosis.

[^]
235.

Thiagalingam S et. al. (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

[^]
236.

Lee V et. al. (2004) Orbitotemporal neurofibromatosis. Clinical features and surgical management.

[^]
237.

Coffin CM et. al. (2004) Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1.

[^]
238.

None (1950) Sarcomatous transformation in multiple neuro-fibromatosis (von Recklinghausen's disease) report of four cases.

[^]
239.

Khosrotehrani K et. al. (2005) Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.

[^]
240.

Schievink WI et. al. (2005) Frequency of incidental intracranial aneurysms in neurofibromatosis type 1.

[^]
241.

Oguzkan S et. al. (2006) Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene.

[^]
242.

Lammert M et. al. (2006) Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.

[^]
243.

Stevenson DA et. al. (2006) Double inactivation of NF1 in tibial pseudarthrosis.

[^]
244.

Bausch B et. al. (2006) Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma.

[^]
245.

Ferner RE et. al. (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

[^]
246.

McCaughan JA et. al. (2007) Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.

[^]
247.

Tong JJ et. al. (2007) Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster.

[^]
248.

Bausch B et. al. (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.

[^]
249.

Maertens O et. al. (2007) Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

[^]
250.

Yan J et. al. (2008) Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1.

[^]
251.

Williams VC et. al. (2009) Neurofibromatosis type 1 revisited.

[^]
252.

Snajderova M et. al. (2012) The importance of advanced parental age in the origin of neurofibromatosis type 1.

[^]
253.

Nguyen R et. al. (2013) Growth behavior of plexiform neurofibromas after surgery.

[^]
254.

Stewart DR et. al. (2014) Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.

[^]
255.

Parrozzani R et. al. (2015) In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients.

[^]